Trial Information

Summary: Parkinson's Disease - Onset of Motor Complications.

The purpose of the study is to test how effective a new formulation of a marketed drug is in increasing the time to onset of dyskinesia (abnormal twisting, writhing movements) in patients who have been taking levodopa for less than 2 years.

Criteria:

• Subjects must be on 600mg or less of levodopa therapy for two years or less.
• Subjects must be on a stable dose of levodopa therapy for at least 4 weeks prior to screening.
• Subject must not have current or past history of Dyskinesia.
• Subject must not be in state of dementia or have a MMSE score < 26 at screening.

Healthy Volunteers: no
Gender: Both
Minimum Age: 30 Years
Maximum Age: 70 Years

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:27 AM